1. Home
  2. WYFI vs BIOA Comparison

WYFI vs BIOA Comparison

Compare WYFI & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WYFI

WhiteFiber Inc. Ordinary Shares

HOLD

Current Price

$26.58

Market Cap

953.8M

Sector

Finance

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$10.22

Market Cap

967.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WYFI
BIOA
Founded
2023
2015
Country
United States
United States
Employees
83
62
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
953.8M
967.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WYFI
BIOA
Price
$26.58
$10.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
6
Target Price
$29.20
$51.50
AVG Volume (30 Days)
2.7M
1.1M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$80.46
$720.93
Revenue Next Year
$89.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.51
$4.26
52 Week High
$46.87
$25.96

Technical Indicators

Market Signals
Indicator
WYFI
BIOA
Relative Strength Index (RSI) N/A 30.01
Support Level N/A $7.61
Resistance Level N/A $13.78
Average True Range (ATR) 0.00 1.51
MACD 0.00 -1.52
Stochastic Oscillator 0.00 13.63

Price Performance

Historical Comparison
WYFI
BIOA

About WYFI WhiteFiber Inc. Ordinary Shares

Whitefiber Inc is a provider of artificial intelligence infrastructure solutions. The company owns high-performance computing data centers and provide cloud-based HPC graphics processing units services, which it terms cloud services, for customers such as AI application and machine learning developers. Its Tier-3 data centers provide hosting and colocation services. Its cloud services support generative AI workstreams, especially training and inference. It has two reportable segments: cloud services and colocation services. The cloud services segment generates revenue from providing high performance computing services to support generative AI workstreams. Colocation services generate revenue by providing customers with physical space, power and cooling within the data center facility.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Share on Social Networks: